Which is a better target for AD immunotherapy, A beta or tau?
Zane
Z
Martin-Jones
Cristian
C
Lasagna-Reeves
D000368:Aged; D000544:Alzheimer Disease / Q000378:metabolism / Q000628:therapy*; D016229:Amyloid beta-Peptides / Q000276:immunology / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000378:metabolism; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D051379:Mice; D014612:Vaccines / Q000276:immunology; D016875:tau Proteins / Q000276:immunology / Q000378:metabolism*
D016229:Amyloid beta-Peptides; D014612:Vaccines; D016875:tau Proteins